Peers & Perspectives

Experts in neurology discuss the use of oral therapies in the treatment of relapsing-remitting multiple sclerosis (MS). They discuss treatment selection based on long-term and real-world data and how recent and emerging therapies will change the management of patients with relapsing-remitting MS.

Advanced practice practitioners discuss the co-occurrence of sleep disorders with other health conditions, patient awareness, and the importance of screening for sleep disorders. They also discuss the treatment landscape of insomnia and the use of dual orexin receptor antagonists in the management of insomnia.

Experts in neurology share considerations for the management of ethnically diverse and underrepresented populations including those of reproductive age.

Expert neurologists review updates in the management of Myasthenia Gravis.

Two multiple sclerosis experts discuss long-term and real-world data with oral therapies in the treatment of relapsing-remitting multiple sclerosis (RRMS) that was presented at ACTRIMS 2022.

Experts in sleep medicine provide key insights on a series of patient cases and evaluate the use of novel agents in the treatment landscape for narcolepsy.

Expert neurologists examine strategies for optimizing treatment formulations in the management of OFF episodes in Parkinson disease and highlight the importance of patient education.

Recommendations to neurologists on appropriately prescribing and managing patients with relapsing-remitting multiple sclerosis using novel, oral therapies.

Elizabeth Thiele, MD, PhD, and Elaine C. Wirrell, MD, discuss the rare pediatric epilepsy conditions Dravet syndrome and Lennox-Gastaut syndrome, from prevalence to the approval of new therapies.

Joseph Sullivan, MD, and Elaine C. Wirrell, MD, discuss the diagnosis, management, and treatment of Dravet Syndrome.

Experts in the diagnosis and treatment of Alzheimer disease discuss the recent approval of aducanumab, its implications on the field, and other promising therapies and diagnostic technologies in development.

Elizabeth Thiele, MD, PhD, and Peter Crino, MD, PhD, discuss the diagnosis and management of tuberous sclerosis complex (TSC) as well as unmet needs in the field.

Vamshi K. Rao, MD, and Eric P. Hoffman, PhD, discuss how dystrophin relates to Duchenne Muscular Dystrophy, current approved therapies, and treatments in development.

A discussion regarding the stigma associated with migraine and the importance of empowering patients and health care professionals to become involved in migraine advocacy.

Experts in neurology Laxman Bahroo, DO and Mindy K. Bixby, DO share insights into the diagnosis, management, and treatment of OFF episodes in Parkinson’s disease and highlight key therapeutic options currently available and in development.

Phyllis Zee, MD, PhD, and Alon Avidan, MD, MPH, provide an overview of behavioral and pharmacological approaches to the management of excessive daytime sleepiness (EDS) and narcolepsy and discuss the recent approval of agents with new mechanisms of action.

Experts review the challenges of managing OFF episodes in Parkinson's disease and the current treatment options to optimize therapy.